Phase 4 Study to Demonstrate Prognostic Usefulness of AdreView™ Scintigraphy for Identifying Subjects With Heart Failure Who Will Experience Death During 60 Months Follow-up.
Clinical trial NCT02127307 · COMPLETED
Trial details
- NCT number
- NCT02127307
- Sponsor
- GE Healthcare
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2014-02-01
- Primary completion
- 2014-12-01
- Enrollment
- 964
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.